Latest in Cardiology from ACC.org

• Is Remnant Cholesterol an Independent CV Risk Factor in Young Adults?
  Most notably in young adults, high levels of remnant cholesterol (remnant-C) confer an independent risk of major adverse cardiovascular events (MACE), even those with optimal levels of LDL-C, and identification of high remnant-C levels at a young age may enhance preventive strategies, according to a study presented at the 17th Asian Pacific Society of Atherosclerosis […]
• Angiographic Control vs Ischemia-Driven Management of Patients Treated With PCI on Left Main With Drug-Eluting Stents
  In the PULSE trial, CCTA following PCI for unprotected left main disease failed to reduce the composite primary endpoint of all-cause death, spontaneous MI, unstable angina, or definite or probable stent thrombosis.
• Olezarsen in Patients With Hypertriglyceridemia at High Cardiovascular Risk
  The Essence-TIMI 73b trial demonstrated that olezarsen, compared with placebo, significantly reduced triglyceride levels in patients with moderate hypertriglyceridemia and elevated cardiovascular risk.
• ACC CardiaCast: Innovation in Action: AI-Enabled ECG: From Concept to Clinical Care
  In this episode with Drs. Francisco Lopez-Jimenez and Paul Friedman, ACC Chief Innovation Officer Dr. Ami Bhatt explores the rapid rise of artificial intelligence (AI) tools in cardiovascular care, highlighting why screening tools such as the electrocardiogram (ECG) are particularly well-suited for innovation.
• ACC Releases Expert Consensus Decision Pathway on TR Evaluation and Management
  The ACC has released a new Expert Consensus Decision Pathway (ECDP) addressing "10 issues for the clinician in tricuspid regurgitation (TR) evaluation and management."